Trends and Resource Utilization in Kawasaki Disease Hospitalizations in the United States, 2008-2017.


Journal

Hospital pediatrics
ISSN: 2154-1671
Titre abrégé: Hosp Pediatr
Pays: United States
ID NLM: 101585349

Informations de publication

Date de publication:
01 03 2022
Historique:
pubmed: 3 2 2022
medline: 15 3 2022
entrez: 2 2 2022
Statut: ppublish

Résumé

To explore trends in hospitalization rate, resource use, and outcomes of Kawasaki Disease (KD) in children in the United States from 2008 to 2017. This was a retrospective, serial cross-sectional analysis of pediatric hospitalizations with International Classification of Disease diagnostic codes for KD in the National Inpatient Sample. Hospitalization rates per 100 000 populations were calculated and stratified by age group, gender, race, and US census region. Prevalence of coronary artery aneurysms (CAA) were expressed as proportions of KD hospitalizations. Resource use was defined in terms of length of stay and hospital cost. Cochran-Armitage and Jonckheere-Terpstra trend tests were used for categorical and continuous variables, respectively. P <.05 was considered significant. A total of 43 028 pediatric hospitalizations identified with KD, yielding an overall hospitalization rate of 5.5 per 100 000 children. The overall KD hospitalization rate remained stable over the study period (P = .18). Although KD hospitalization rates differed by age group, gender, race, and census region, a significant increase was observed among Native Americans (P = .048). Rates of CAA among KD hospitalization increased from 2.4% to 6.8% (P = .04). Length of stay remained stable at 2 to 3 days, but inflation-adjusted hospital cost increased from $6819 in 2008 to $10 061 in 2017 (Ptrend < 0.001). Hospitalization-associated costs and rates of CAA diagnostic codes among KD hospitalizations increased, despite a stable KD hospitalization rate between 2008 and 2017. These findings warrant further investigation and confirmation with databases with granular clinical information.

Identifiants

pubmed: 35106586
pii: 184669
doi: 10.1542/hpeds.2021-006142
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

257-266

Informations de copyright

Copyright © 2022 by the American Academy of Pediatrics.

Auteurs

Rhythm Vasudeva (R)

Department of Pediatrics, University of Kansas School of Medicine, Wichita, Kansas.

Frank Adusei Poku (FA)

University of Oklahoma, Oklahoma City, Oklahoma.

Mary Thommana (M)

K. J. Somaiya Medical College & Research Centre, Mumbai, India.

Garima Parmar (G)

Department of Pediatrics, Kasturba Medical College, Mangalore, India.

Jacob Umscheid (J)

Department of Pediatrics, University of Kansas School of Medicine, Wichita, Kansas.

Narendrasinh Parmar (N)

Department of Pediatrics, Brookdale University Hospital Medical Center, Brooklyn, New York.

Comfort A Koranteng (CA)

The Pentecost Hospital, Accra, Ghana.

Aastha Singh (A)

Maulana Azad Medical College, New Delhi, India.

Kripa Patel (K)

Smt. NHL Municipal Medical College, Ahmedabad, India.

Priyank Yagnik (P)

Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.

Keyur Donda (K)

Department of Pediatrics, University South Florida, Tampa, Florida.

Parth Bhatt (P)

Department of Pediatrics, United Hospital Center, Bridgeport, West Virginia.

Fredrick Dapaah-Siakwan (F)

Neonatal Intensive Care Unit, Valley Children's Hospital, Madera, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH